These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12388930)

  • 1. Colostrinin proline-rich polypeptide complex from ovine colostrum--a long-term study of its efficacy in Alzheimer's disease.
    Leszek J; Inglot AD; Janusz M; Byczkiewicz F; Kiejna A; Georgiades J; Lisowski J
    Med Sci Monit; 2002 Oct; 8(10):PI93-6. PubMed ID: 12388930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colostrinin: a proline-rich polypeptide (PRP) complex isolated from ovine colostrum for treatment of Alzheimer's disease. A double-blind, placebo-controlled study.
    Leszek J; Inglot AD; Janusz M; Lisowski J; Krukowska K; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1999; 47(6):377-85. PubMed ID: 10608295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colostrinin: a proline-rich polypeptide complex of potential therapeutic interest.
    Janusz M; Zabłocka A
    Cell Mol Biol (Noisy-le-grand); 2013 Nov; 59(1):4-11. PubMed ID: 24200016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proline-rich polypeptide complex and its nonapeptide fragment inhibit nitric oxide production induced in mice.
    Zabłocka A; Janusz M; Macała J; Lisowski J
    Regul Pept; 2005 Feb; 125(1-3):35-9. PubMed ID: 15582711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technology evaluation: colostrinin, ReGen.
    Rattray M
    Curr Opin Mol Ther; 2005 Feb; 7(1):78-84. PubMed ID: 15732533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colostrinin (a naturally occurring, proline-rich, polypeptide mixture) in the treatment of Alzheimer's disease.
    Bilikiewicz A; Gaus W
    J Alzheimers Dis; 2004 Feb; 6(1):17-26. PubMed ID: 15004324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proline-rich polypeptide complex (PRP) from ovine colostrum. Studies on the effect of PRP on nitric oxide (NO) production induced by LPS in THP-1 cells.
    Mikulska JE; Lisowski J
    Immunopharmacol Immunotoxicol; 2003 Nov; 25(4):645-54. PubMed ID: 14686804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proline-rich polypeptide complex (PRP) isolated from ovine colostrum. Modulation of H2O2 and cytokine induction in human leukocytes.
    Zabłocka A; Janusz M; Macała J; Lisowski J
    Int Immunopharmacol; 2007 Jul; 7(7):981-8. PubMed ID: 17499201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colostrinine: a proline-rich polypeptide from ovine colostrum is a modest cytokine inducer in human leukocytes.
    Inglot AD; Janusz M; Lisowski J
    Arch Immunol Ther Exp (Warsz); 1996; 44(4):215-24. PubMed ID: 9017161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proline-rich polypeptide from ovine colostrum: colostrinin with immunomodulatory activity.
    Zimecki M
    Adv Exp Med Biol; 2008; 606():241-50. PubMed ID: 18183932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
    Burns A; Gauthier S; Perdomo C
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proline-rich polypeptides in Alzheimer's disease and neurodegenerative disorders -- therapeutic potential or a mirage?
    Gladkevich A; Bosker F; Korf J; Yenkoyan K; Vahradyan H; Aghajanov M
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1347-55. PubMed ID: 17630064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colostral proline-rich polypeptides--immunoregulatory properties and prospects of therapeutic use in Alzheimer's disease.
    Janusz M; Zabłocka A
    Curr Alzheimer Res; 2010 Jun; 7(4):323-33. PubMed ID: 19939229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mechanism of action of a proline-rich polypeptide complex (PRP): effect on the stage of cell differentiation.
    Kubis A; Marcinkowska E; Janusz M; Lisowski J
    Peptides; 2005 Nov; 26(11):2188-92. PubMed ID: 15904991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
    Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of colostrinin, an immunomodulatory proline-rich polypeptide from ovine colostrum, on sialidase and beta-galactosidase activities in murine thymocytes.
    Sokal I; Janusz M; Miecznikowska H; Kupryszewski G; Lisowski J
    Arch Immunol Ther Exp (Warsz); 1998; 46(3):193-8. PubMed ID: 9704152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovine colostrum nanopeptide affects amyloid beta aggregation.
    Janusz M; Woszczyna M; Lisowski M; Kubis A; Macała J; Gotszalk T; Lisowski J
    FEBS Lett; 2009 Jan; 583(1):190-6. PubMed ID: 19084010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
    Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D
    Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.